Echo Therapeutics, Inc. (ECTE) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Join SI Premium – FREE
Echo Therapeutics, Inc. (NASDAQ: ECTE) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
